Related Experiment Video
Updated: Nov 18, 2025

Use of the Scissor-Type Knife During the Peroral Endoscopy Myotomy Procedure for the Treatment of Achalasia
Published on: March 3, 2023
Does Premedication with Mucolytic Agents Improve Mucosal Visualization during Oesophagogastroduodenoscopy: A
Eoghan Burke1, Patricia Harkins2, Frank Moriarty3
1Our Lady of Lourdes Hospital, Drogheda, Co Louth, Ireland.
Premedication with mucolytic agents significantly improves gastric mucosal visibility during oesophagogastroduodenoscopy (OGD) for early gastric cancer detection. This safe and effective strategy enhances diagnostic accuracy without reported adverse events.
Area of Science:
- Gastroenterology
- Oncology
- Medical Diagnostics
Background:
- Gastric cancer (GC) is a leading cause of cancer mortality globally.
- Oesophagogastroduodenoscopy (OGD) is the standard for GC diagnosis.
- Gastric mucus impedes early GC detection during OGD.
Purpose of the Study:
- To evaluate the efficacy of mucolytic agents as premedication for improving mucosal visibility during OGD.
- To compare mucolytic agents against placebo or other mucolytics in adults undergoing elective OGD.
Main Methods:
- Systematic review and random-effects meta-analysis of 13 studies (11,086 patients).
- Searched PubMed, EMBASE, CINAHL, CENTRAL, and Web of Science.
- Analyzed total mucosal visibility scores (TMVS) and subgroup analyses for simethicone, dosage, and timing.
Main Results:
- Pooled mucolytic agents showed a significant improvement in TMVS (mean difference -2.69).
- Simethicone demonstrated effectiveness (mean difference -2.68), with 133mg being optimal (mean difference -4.22).
- Premedication >20 minutes prior improved TMVS (mean difference -3.68); no adverse events were reported.
Conclusions:
- Routine premedication with mucolytic agents enhances TMVS during OGD.
- This intervention improves diagnostic potential for early gastric cancer.
- The use of mucolytic agents is safe, with no adverse events noted.
Related Concept Videos
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Endoscopic Procedures I: Esophagogastroduodenoscopy
During an EGD, the endoscope can be used to:
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Endoscopic Studies I: Bronchoscopy and Thoracoscopy
Bronchoscopy
Description
Bronchoscopy is a procedure that involves direct visualization of the larynx, trachea, and bronchi for diagnostic and therapeutic purposes. A flexible fiber optic or rigid bronchoscope is used to carry out the procedure. The fiber-optic bronchoscope is more frequently used due...
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Endoscopic Procedures III: Video Capsule Endoscopy

